Tillotts Pharma is strengthening its presence in the German market: the Berlin office was opened in January 2017 under the management of Magdalena Kritikos. The portfolio includes Entocort® for the treatment of Crohn’s disease, Asacol® for the treatment of ulcerative colitis, and VistaPrep® for bowel preparation before endoscopy. With further innovative solutions, the Swiss specialty pharmaceutical company focused on the treatment of gastrointestinal (GI) diseases will expand its global footprint with its growing presence in Germany and will continue to work to improve the quality ...

Some patients with Crohn’s disease, a chronic inflammatory disease that affects the lining of the digestive tract, require surgery to remove part or all of the large intestine; however, surgery does not cure the condition and many patients relapse after surgery. A new review and analysis of published studies provides insights on the rates of relapse and predictors of relapse ...